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Abstract
The murine thymus produces discrete γδ T cell subsets making either interferon-γ (IFN--γ) or 
interleukin 17 (IL-17), but the role of the TCR in this developmental process remains 
controversial. Here we show that mice haploinsufficient for both Cd3g and Cd3d (CD3DH, for 
CD3 double haploinsufficient) have reduced TCR expression and signaling strength selectively on 
γδ T cells. CD3DH mice had normal numbers and phenotype of αβ thymocyte subsets but 
impaired differentiation of fetal Vγ6+ (but not Vγ4+) IL-17-producing γδ T cells and a marked 
depletion of IFN-γ-producing CD122+ NK1.1+ γδ T cells throughout ontogeny. Adult CD3DH 
mice showed reduced peripheral IFN-γ+ γδ T cells and were resistant to experimental cerebral 
malaria. Thus, TCR signal strength within specific thymic developmental windows is a major 
determinant of the generation of proinflammatory γδ T cell subsets and their impact on 
pathophysiology.
Proinflammatory cytokines orchestrate protective immune responses to pathogens and 
tumors, but are also responsible for tissue-damaging inflammation and autoimmunity. 
Among various cellular sources, γδ T cells have emerged as major producers of interferon-γ 
(IFN-γ) and/ or interleukin 17 (IL-17) in several diseases. On one hand, IFN-γ production by 
γδ T cells underlies protective responses to infections1, as well as tumor immunity2, but, 
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conversely, it is associated with susceptibility to severe malaria3. On the other hand, IL-17 
secretion by γδ T cells is a key defense mechanism against various bacterial infections, such 
as Staphylococcus aureus4 or Listeria monocytogenes4, 5, but is also a critical component of 
inflammatory and autoimmune syndromes like psoriasis6-8, colitis9, chronic granulomatous 
disease10, ischemic brain inflammation11 and experimental autoimmune 
encephalomyelitis12-14.
The non-redundant roles of IFN-γ-producing (IFN-γ+) and IL-17-producing (IL-17+ ) γδ T 
cells are tightly linked to “developmental pre-programming” in the murine thymus15. 
Whereas conventional effector CD4+ T cells differentiate in peripheral lymphoid organs in 
response to antigen and additional environmental cues, γδ T cells complete their functional 
maturation in the thymus. On the basis of CD27 and CCR6 expression, the murine thymus 
generates discrete populations of IFN-γ+ and IL-17+ γδ T cells 16, 12, 17. Importantly, these 
subpopulations have different functions: for example, CD27− IL-17+ γδ T cells promote 
tumor cell growth18, 19 whereas CD27+ IFN-γ+ γδ T cells inhibit it2, 20. It is therefore critical 
to understand how distinct functional γδ T cell subsets are generated and regulated.
Given its pivotal role in thymocyte development and selection, the T cell receptor (TCR) is a 
likely determinant of the functional differentiation of γδ T cells15. It was shown that 
T10/T22 tetramer-specific γδ T cells, which account for ~0.4% of peripheral γδ T cells, 
produced IL-17 or IFN-γ in the absence or presence, respectively, of thymic T10/T22 
expression12. Consistent with this, thymic selection drives dendritic epidermal T cells 
(DETC) that populate the mouse epidermis towards IFN-γ but away from IL-17 
production21. However, SKG mice, which are hypomorphic for the TCR signal-transducing 
kinase ZAP70, retaining only 10% of its signaling ability, showed impaired development of 
IL-17+ γδ T cells22. As such, the role of TCR signal “strength” in the development of 
proinflammatory γδ T cell subsets remains unclear.
TCR signal strength is known to control the earliest stage of γδ T cell development, i.e., 
lineage commitment23. The manipulation of signal transduction in TCR transgenic T cells 
influenced the γδ versus αβ thymocyte fate24, 25, with γδ T cells requiring stronger TCR 
signaling than αβ T cells to develop. However, the impact on subsequent maturation of γδ T 
cells, particularly IFN-γ+ versus IL-17+ γδ T cells, was not assessed. On the other hand, 
models based on a single transgenic TCR may not be ideal to answer this question, because 
γδ T cell development is tightly linked to the dynamics of TCR rearrangements during 
ontogeny. Indeed, “developmental waves” with distinct TCR gene usage populate different 
peripheral tissues, and distinct TCRγ chain variable region (Vγ) repertoires can have 
significant biases towards either IFN-γ or IL-17 production16, 26. For example, of the two 
main γδ T cell subsets in peripheral lymphoid organs, Vγ1+ T cells preferentially secrete 
IFN-γ, whereas Vγ4+ T cells are biased towards IL-1716, 26. In addition, Vγ5+ T cells 
generated around embryonic days E15-E16 do not secrete IL-17, while this cytokine is 
abundantly produced by Vγ6+ T cells that differentiate at E17-E18. Moreover, in-depth 
transcriptional profiling of γδ thymocyte subsets by the Immunological Genome Project 
(www.immgen.org) demonstrated a divergence between the transcriptional networks of 
IL-17 -biased Vγ6+ and Vγ4+ T cells versus IFN-γ-biased Vγ5+ and Vγ1+ T cells27, 28.
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The association between certain γδ TCR repertoires and differential IFN-γ or IL-17 
production26 suggests that TCR signaling is a major determinant of the functional 
differentiation of γδ T cells in the thymus. However, testing this hypothesis has been 
hampered by the lack of mouse models that specifically interfere with TCRγδ signaling in 
vivo. Here we describe a selective defect in the surface expression of TCRγδ, but not 
TCRαβ, in Cd3g+/− Cd3d+/− mice (CD3DH, for CD3 double haploinsufficient), and show 
that reduced TCRγδ signaling impacts on the differentiation of discrete subsets of IFN-γ and 
IL-17-producing γδ T cells during thymic ontogeny with pathological consequences.
Results
Cd3d+/−Cd3g+/− mice show reduced TCR signaling in γδ T cells
During the screening of various lines of (single or double) haploinsufficient CD3 mutants, 
we observed that Cd3d+/−Cd3g+/− mice (hereafter CD3DH, for double haploinsufficient) had 
markedly lower cell surface expression of TCRγδ and CD3ε (Fig. 1a,b) and reduced γδ 
thymocyte numbers (Fig. 1c). This reduction was not observed in single haploinsufficient, 
Cd3d+/− or Cd3g+/− mice (Supplementary Fig. 1a), and was more severe than that observed 
in CD3δ-deficient mice29 (Supplementary Fig. 1b). The reduced numbers of γδ thymocytes 
in CD3DH mice were not due to increased cell death (Supplementary Fig. 1c), suggesting 
that lower TCRγδ expression impaired γδ T cell development, as reported in transgenic 
models24, 25. CD3DH γδ thymocytes remained mostly CD4− CD8− (data not shown), thus 
excluding diversion into the αβ lineage. On the other hand, TCRαβ expression was not 
affected, and αβ thymocyte development proceeded normally in CD3DH mice (Fig. 1d-f). 
Consistent with normal TCRαβ signaling and selection, the generation of agonist-selected 
Foxp3+ CD4+ and CD1d-restricted NKT cells was similar to wild-type mice (Supplementary 
Fig. 1d,e).
To characterize the downstream effects of reduced TCRγδ expression we assessed the 
expression of agonist selection markers, namely CD73, a signature of TCRγδ signaling 
during thymic development30, and CD5, a stable indicator of TCR signal strength31, as well 
as the maturation markers CD122 and CD4412, 15, 17. All were markedly reduced in γδ 
thymocytes from CD3DH compared to wild-type mice (Fig. 1g). Upon TCR stimulation, the 
activation markers CD69 and CD25 were also decreased in peripheral (splenic) CD3DH γδ 
T cells (Fig. 1h). Moreover, CD3DH γδ T cells had lower TCR responsiveness in terms of 
ERK (Fig. 1i) and AKT (Supplementary Fig. 2a) activation or calcium mobilization 
(Supplementary Fig. 2b) compared to wild-type γδ T cells. These data indicate that lower 
surface TCRγδ expression in Cd3d+/−Cd3g+/− mice impairs signal transduction and 
downstream TCR-dependent processes.
To test whether the phenotype of γδ T cells in CD3DH mice was cell-intrinsic, we 
established mixed (1:1) bone marrow (BM) chimeras by transferring CD3DH (Thy-1.2) and 
wild-type (Thy-1.1) whole BM cells into either TCRδ-deficient or RAG2-deficient hosts. In 
both hosts we observed reduced TCRγδ expression in CD3DH-derived γδ thymocytes (Fig. 
1j), which consistently accounted for a minor fraction of the total γδ thymocyte pool, 
compared to wild-type γδ thymocytes. In contrast, αβ thymocytes were evenly generated 
from CD3DH or wild-type precursors (Fig. 1k), indicating that CD3DH progenitors are 
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outcompeted by wild-type precursors for γδ, but not αβ T cell development. Of note, this 
disadvantage could be compensated by using a 1:9 WT: CD3DH ratio (Supplementary Fig. 
3), which indicated that CD3DH progenitors can generate γδ thymocytes albeit with reduced 
potency compared to wild-type precursors. Thus, haploinsufficiency for both Cd3d and 
Cd3g results in lower TCRγδ expression levels and signaling and reduced numbers of γδ 
thymocytes.
Impaired differentiation of IL-17+ and IFN-γ+ γδ T cell subsets
We next analyzed the functional differentiation of γδ T cell subsets. Development of CD27+ 
and CD27− γδ T cells was observed during the embryonic stages and continued into 
adulthood (Fig. 2a), as previously reported. 16 Both IFN-γ+ and IL-17+ γδ thymocytes were 
observed in reduced frequencies in CD3DH compared to wild-type E18 embryos (Fig. 2b, 
c). Whereas the reduction in IFN-γ+ γδ thymocytes was maintained after birth into 
adulthood, the frequency of IL-17+ γδ thymocytes in CD3DH mice normalized to wild-type 
levels between 1 and 6 weeks of age (Fig. 2b-d). This coincided with a switch in TCR Vγ 
usage: most IL-17+ γδ T cells are Vγ1− Vγ4-(validated as Vγ6+ by GL3/ 17D1 antibody 
staining as in18, not shown) in E18 embryos and neonates, and Vγ4+ from week 1 onwards 
(Fig. 2e). Of note, IL-17+ Vγ6+ cells are generated exclusively during embryonic life32. 
Importantly, only Vγ6+ but not Vγ4+ thymocytes showed reduced IL-17 production in 
CD3DH mice (Fig. 2f). These data suggest that the effector γδ T cell subsets generated 
within distinct developmental windows, as marked by particular Vγ usage, have distinct 
TCR signal strength requirements.
Transcriptional signatures of TCR signal strength in γδ T cells
Because developmental programming of γδ T cells is set at the transcriptional level27, 33, 34, 
we performed transcriptome-wide analysis of sorted total γδ thymocytes from CD3DH or 
wild-type mice at E18 of embryonic development or at 6-week of age. This analysis showed 
highly dynamic patterns of gene expression during ontogeny (Fig. 3a). Among the mRNAs 
upregulated in γδ thymocytes from E18 to adult in wild-type mice, those linked to IFN-γ 
production were generally impaired in CD3DH γδ thymocytes, such as Nr4a3, Nr4a2 and 
Bcl2a116, 34, 35, the transcription factors Egr2, Egr3 and Id3, which are major suppressors of 
the IL-17 differentiation pathway21, and Nfkbiz (which encodes the transcription factor 
IκBζ)36, Tnfrsf18 (encoding GITR), Gp49a and Lilrb4 (encoding Gp49b)37, which are 
involved in the regulation of IFN-γ production (Fig. 3a, Supplementary Fig. 4a).
On the other hand, key type 17 genes, such as Il17a, Il17f and Il23r 13,33, which are highly 
expressed in fetal γδ thymocytes and reduced in adult γδ thymocytes in wild-type mice, were 
downregulated in CD3DH γδ thymocytes (Fig. 3a). Both wild-type and CD3DH γδ 
thymocytes downregulated the embryonically rearranged TCRs, such as Vγ5 and Vγ6, as 
well as the transcription factor PLZF (encoded by Zbtb16), which is characteristic of fetal γδ 
thymocytes27(Fig. 3a).
The type 17 signature genes Sox 4 and Sox13 (ref 27, 28) were greatly reduced in 
embryonic Vγ6+, but not Vγ4+ CD3DH (compared to wild-type) thymocytes 
(Supplementary Fig. 4b), indicating that the IL-17+Vγ6+and IL-17+Vγ4+ thymocyte subsets 
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have.distinct developmental TCR signal strength requirements. Of note, the expression of 
Tbx21 (which encodes T- bet) and Rorc (which encodes RORγt), which transcriptionally 
regulate Ifng and Il17a expression respectively, was not affected in CD3DH compared to 
wild-type γδ thymocytes (data not shown).
Next, for a TCR-mediated gain-of-function approach, we stimulated total γδ thymocytes 
from adult CD3DH or wild-type mice with saturating amounts of anti-CD3ε mAb for 16 
hours, to achieve crosslinking of all available T C R complexes on the cell surface. We 
observed an upregulation of Egr2 and Egr3 expression in wild-type γδ thymocytes (Fig. 3b), 
consistent with their induction by strong TCR signals21. Egr2 and Egr3 upregulation was 
also observed in stimulated CD3DH γδ thymocytes (Fig. 3b), suggesting that increasing γδ 
TCR signaling can rescue the expression of IFN-γ-associated transcriptional signatures in 
CD3DH γδ thymocytes. In addition, anti-CD3ε mAb stimulation downregulated the type 17 
signature genes, such as Sox428, Il23r and Il1r113, 33, 38, in both wild-type and CD3DH γδ 
thymocytes (Fig. 3b). Collectively, these data suggest that strong TCR signals are required to 
promote IFN-γ at the expense of IL-17 production by adult γδ thymocytes.
CD3DH mice lack IFN-γhi CD122+ NK1.1+ γδ thymocytes
We next tested if the deficiency in IFN-γ expression in γδ thymocytes from CD3DH mice 
involved the depletion of a specific γδ T cell subset committed to IFN-γ production. Thus, 
we analyzed the expression of CD122 (ref12) and NK1.1 (ref17,30), two markers previously 
associated with IFN-γ+ γδ T cells, on adult CD27+ γδ T cells. We detected a CD122+ 
NK1.1+ γδ T cell population in the wild-type thymus that was absent in CD3DH mice (Fig. 
4a, b). CD122+ NK1.1− γδ T cells, likely precursors of CD122+ NK1.1+ γδ T cells, were 
also reduced in the CD3DH thymus compared to wild-type (Fig. 4a). The Vγ repertoire 
changed from Vγ4-biased to Vγ1-enriched between the CD122− and the more mature 
CD122+ γδ T cells in wild-type thymi (Fig. 4c), suggesting that TCR selection shapes the 
mature γδ thymocyte pool. Furthermore, consistent with a requirement for strong TCR 
signaling, wild-type CD122+ NK1.1+ γδ thymocytes had high expression of the selection 
markers CD44, CD73 and CD45RB, which were not detected on CD122− γδ thymocytes 
(Fig. 4d). Importantly, wild-type CD122+ NK1.1+ γδ thymocytes had the highest expression 
of IFN-γ (Fig. 4d), suggesting that the high IFN-γ---producing γδ T cells have a 
differentiation defect in CD3DH mice. Furthermore, in mixed WT:CD3DH BM chimeras, 
CD27+ CD122+ NK1.1+ γδ thymocytes were exclusively generated from wild-type 
progenitors (Fig. 4e). This observation was made in both 1:1 and 1:9 chimeras (Fig. 4e), 
indicating a strong competitive disadvantage of CD3DH precursors along this developmental 
pathway.
We next aimed to rescue the generation of CD122+ NK1.1+ γδ thymocytes in CD3DH mice 
by cross-linking their TCR complex in vivo. Intraperitoneal injection of the 17A2 antibody, 
which cross-links CD3εγ dimers, rescued CD122+ NK1.1+ γδ thymocyte development in 
CD3DH mice, leading to frequencies similar to wild-type mice (Fig. 4f, g). Moreover, wild-
type mice treated with 17A2 showed an increase in CD122+ NK1.1+ γδ thymocytes 
compared to untreated wild-type mice (Fig. 4a, f). These data indicate that strong TCR 
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signaling promotes (and is required for) the development of the IFN-γhi CD27+ CD122+ 
NK1.1+ γδ thymocyte subset.
Reduced IFN-γ+ γδ splenocytes and resistance to cerebral malaria
We next investigated the consequences of reduced γδ TCR signaling in CD3DH mice on 
peripheral γδ T cells. Upon ex vivo PMA+ionomycin stimulation, CD3DH splenocytes 
showed reduced CD27+ IFN-γ+ but normal CD27− IL-17+ γδ T cell frequencies compared to 
wild-type splenocytes (Fig. 5a, b). In contrast, CD3DH CD4+ αβ T cells differentiated 
normally into Th1 cells when activated in the presence of IL- 12 (Supplementary Fig. 5), 
indicating that the IFN-γ defect of CD3DH mice was selective for γδ T cells. Moreover, 
CD27+ CD122+ NK1.1+ CD44+ γδ splenocytes were absent in CD3DH compared to wild-
type mice (Fig. 5c-f). This was also observed in competitive WT:CD3DH BM chimeras, 
both at 1:1 and 1:9 ratios (Fig. 5e).
We next assessed the physiological importance of IFN-γ-producing γδ T cells in a model of 
cerebral malaria, which in C57BL/6 mice induces IFN-γ-dependent pathology39 and in both 
mice and humans3 requires a major contribution from γδ T cells. We induced experimental 
cerebral malaria with Plasmodium berghei ANKA sporozoites, thus establishing a liver-
stage infection before spreading to the blood, which is the symptomatic stage. Whereas 
wild-type mice presented an abundant IFN-γ+ γδ T cell population in the spleen at day 5 
post-infection (blood stage), this was markedly reduced in CD3DH mice (Fig. 5g), and 
associated with higher parasitemia (measured as % of infected red blood cells) compared to 
infected wild-type mice (Fig. 5h). Neurological symptoms appeared in wild-type mice 
around day 6 post-infection and became fatal in all animals by days 7-10 (Fig. 5i). By 
contrast, γδ T cell-deficient (TCRδ-deficient), as well as most CD3DH mice remained 
healthy and survived (Fig. 5i). These data demonstrate that IFN-γ+ γδ T cells make mice 
highly susceptible to fatal inflammatory syndromes like severe malaria.
Discussion
The reduced TCRγδ expression on the surface of γδ thymocytes in CD3DH mice allowed us 
to examine a diverse, polyclonal TCRγδ repertoire, which is highly valuable given the 
association between specific TCR gene usage and functional differentiation biases26. Our 
results suggest that distinct developmental γδ T cell subsets defined by TCRVG 
rearrangement and Vγ usage have distinct TCR signal strength requirements for 
differentiation into IFN-γ- or IL-17-producing cells.
CD3δ was shown to be absent from mouse mature TCRγδ complexes42, 43, which raises the 
question how it impacts surface TCRγδ expression. As we found no evidence for the 
presence of CD3δ on the surface of γδ thymocytes (data not shown), we are currently 
investigating the possibility that CD3δ transiently participates in TCRγδ assembly. Also, 
changes in the relative intracellular amounts of CD3 chains as observed in CD3DH mice 
could cause abnormal glycosylation of CD3δ 44, 45 (data not shown) and/or CD3γ46, which 
in turn could impair the assembly and stability of nascent TCR complexes, and ultimately 
their surface expression and signaling 41, 46. TCR signaling strength impacts thymic 
commitment to the αβ versus γδ lineages23-25. Consistent with this, CD3DH mice showed 
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reduced numbers of total γδ thymocytes, including loss of CD122+ NK1.1+ γδ T cells 
(expressing high IFN-γ levels). The number and frequencies of αβ T cell subsets, including 
thymic regulatory ( Treg) and invariant NKT (iNKT) cells, was normal in CD3DH mice, 
although the repertoire of TCRαβ+ subpopulations was not assessed. However, the 
expression of the αβ TCR was normal in developing CD3DH thymocytes, indicating that the 
reduction in TCR expression was specific to γδ thymocytes.
Interestingly, whereas IL-17+ Vγ6+ cells were underrepresented in CD3DH mice, their 
IL-17+ Vγ4+ counterparts were not affected, consistent with distinct developmental 
requirements for the two IL-17-producing γδ T cell subsets32. Vγ6+ thymocytes have been 
shown to outcompete Vγ4+ thymocytes when reconstituting the dermis of γδ T cell-deficient 
mice8, and whereas fetal-derived (and thymically programmed) Vγ6+ T cells were shown to 
be resident in the dermis, adult BM-derived Vγ4+ T cells seem to depend on extrathymic 
signals to migrate to the skin. Thus, by differentially controlling tissue homing properties, 
thymic programming may determine the pathophysiological contributions of discrete γδ T 
cell subsets. Consistent with this, Vγ4+ T cells represent the major source of IL-17 in 
psoriasis-like inflammation8, 32, as well as in experimental autoimmune encephalomyelitis13 
and collagen-induced arthritis48, whereas Vγ6+ T cells are more frequent in Listeria 
infection5 and ovarian cancer18.
The observation that fetal-derived and adult IL-17-producing γδ T cells have distinct TCR 
signaling requirements could not be obtained using the available ( Vγ4-based) transgenic 
TCRγδ models, and resolves previous controversies on the TCR (in)dependence of IL-17+ 
γδ T cell development12, 21, 22, 28. Namely, our data indicates that Vγ6+, but not Vγ4+, 
thymocytes depend on strong TCR signals for functional differentiation, which in turn 
warrants investigation into their respective ligand engagement requirements.
In addition to ligand engagement, distinct signaling cascades downstream of the TCRγδ may 
differentially affect γδ T cell subsets. It will be important to establish if TCRγδ signaling is 
perceived mostly quantitatively or, rather, qualitatively based on the engagement of distinct 
signaling pathways, such as ERK-MAPK or PI3K-AKT (Nital Sumaria, B.S.-S. and D. J. P., 
unpublished results). Further downstream in cellular programming, our transcriptional 
analysis of fetal and adult total γδ thymocytes stages showed that CD3DH γδ thymocytes 
efficiently downregulated the IL-17 program, but were deficient in upregulating the IFN-γ 
pathway between fetal and adult stages. Particularly affected were the transcription factors 
Egr2, Egr3 and Id3, which are induced by agonist TCR signaling21, 50, and may be required 
to suppress a “default” RORγt-dependent IL-17 program and maximize IFN-γ production in 
γδ thymocytes. This would be consistent with both the repression of the IL-17 pathway in 
Vγ5+ DETC development21 and the depletion, in CD3DH mice, of Vγ1-biased CD27+ 
CD122+ NK1.1+ γδ T cells, the subset expressing the highest IFN-γ on a per cell basis.
Interestingly, the transcription factors that control Ifng and Il17a expression, T-bet and 
RORγt, were normally expressed in CD3DH γδ T cell subsets, suggesting that the γδ T cell 
differentiation phenotype in these mice derives from mechanisms downstream of T-bet or 
RORγt expression. This is in agreement with normal expression of these transcription factors 
in γδ thymocytes deficient for the TCR signal transducer Itk28. We therefore propose that a 
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major function of TCRγδ signaling is to select preprogrammed precursors, which could 
resemble innate lymphoid cells (ILC), for differentiation into effector cells making IFN-γ or 
IL-17. Future studies on the functional similarities and differences between ILC and γδ T 
cell subsets may contribute to understanding the evolutionary conservation of these innate-
like lymphocytes and their therapeutic potential for infectious or inflammatory diseases and 
cancer20.
Online methods
Mice
Adult mice were used at 4–8 weeks of age. Embryos were obtained by the setting up of 
timed pregnancies. C57BL/6 (WT) mice were from Charles River Laboratories. CD3γ−/− 
mice have been previously described51, and were kindly given by Dr. D. Kappes (Fox Chase 
Cancer Center, Philadelphia). CD3δ−/− have been previously described29 and were yield by 
Dr. I. Luescher (Ludwig Institute for Cancer Research, Lausanne). Double heterozygotes 
(CD3DH) were obtained by crossing CD3γ−/− males with CD3δ−/− females. For the studies, 
both males and females were used. Mice were bred and maintained in the pathogen–free 
animal facilities of the Instituto de Medicina Molecular (Lisbon) and Animalario 
Universidad Complutense (Madrid). All experiments involving animals were done in 
compliance with the relevant laws and institutional guidelines.. Experimental procedures 
were ethically approved by the Ethics Committee for Animal Experimentation of 
Universidad Complutense and Comunidad de Madrid, and by the institutional animal 
welfare body – ORBEA-iMM – and by the DGAV (Portuguese competent authority for 
animal protection), all in accordance with Directive 2010/63/EU.
Bone marrow chimeras
Rag2−/− or Tcrd−/− mice were lethally irradiated (900 rad), and the next day injected 
intravenously with a total of 107 whole bone marrow cells of mixed (1:1 or 1:9) WT.Thy-1.1 
and CD3DH.Thy-1.2 origin. Chimeras were kept on antibiotics-containing water (2% 
Bactrim; Roche) for the first 4 weeks post-irradiation. The hematopoietic compartment was 
allowed to reconstitute for 6 weeks before organs were harvested for flow cytometry 
analysis.
Cell preparations
Thymuses, lymph nodes and spleens were homogenized and washed in RPMI medium 
containing 10% (vol/vol) FCS. Splenocytes were depleted from erythrocytes using the Red 
Blood Cell Lysis buffer 1x (Biolegend).
Monoclonal antibodies
Listed in Supplementary Table 1.
Flow cytometry and cell sorting
For cell surface staining, thymocytes, erythrocyte-depleted splenocytes or lymph node cells 
were incubated 30 min with saturating concentrations of mAbs identified above. For 
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intracellular cytokine staining, cells were stimulated with PMA (phorbol 12-myristate 13-
acetate) (50ng/mL) and ionomycin (1μg/mL), in the presence of Brefeldin A (10μg/mL) (all 
from Sigma) for 4h at 37°C. Cells were stained for the identified above cell surface markers, 
fixed 30min at 4°C and permeabilized with the Foxp3/Transcription Factor Staining Buffer 
set (eBioscience) in the presence of anti-CD16/CD32 (93) (eBioscience) for 15 min at 4°C, 
and finally incubated for 1h at room temperature with identified above cytokine-specific Abs 
in permeabilization buffer. Samples were acquired using FACSFortessa (BD Biosciences). 
Data were analysed using FlowJo software (Tree Star). Live indicated subsets were 
electronically sorted when indicated using FACSAria (BD Biosciences).
Cell culture
For early activation markers, cells were incubated for 24h on plate-bound anti-CD3e (10 
mg/ml) and anlalyzed by flow citometry. For phosphorylated molecules downstream of TCR 
vs isotype-matched control antibody, sorted lymph node cells were stimulated for 5 min with 
soluble anti-CD3ε (10 μg/ml) then fixed 30min at 4°C and permeabilized with the Foxp3/
Transcription Factor Staining Buffer set (eBioscience) in the presence of anti CD16/CD32 
Fc Block (93) (eBioscience) for 30min at room temperature, and finally incubated for 1h at 
room temperature with identified above anti-p-ERK Abs in permeabilization buffer. For Th1 
polarization CD4+ αβ T cells were isolated by flow cytometry and incubated for 4 days on 
plate-bound anti-CD3ε and anti-CD28 (5ng/ml each). When indicated (Th1 cocktail), the 
following cytokines and neutralizing antibody were added to the culture milieu: IL-2 (10 
ng/ml; Preprotech), IL-12 (50 ng/ml; Preprotech) and anti-IL-4 (11B11) (10 μg/mL; 
eBiosciences).
Malaria infection
Mice were infected as described52.
RNA Isolation, cDNA Production, and Real-Time PCR
Total RNA was extracted using the RNeasy Mini kit (Qiagen) according to the 
manufacturer’s instructions. Concentration and purity were determined using the NanoDrop 
ND-1000 spectrophotometer (Thermo Scientific). Total RNA was reverse transcribed into 
cDNA using a Transcriptor High Fidelity cDNA Synthesis kit (Roche). Quantitative real-
time PCR was performed on ViiA 7 Real-Time PCR system (Applied Biosystems; Life 
Technologies). Primers were either designed manually or by using the Universal 
ProbeLibrary Assay Design Center from Roche (www.roche-applied-science.com). 
Sequences are available upon request. Analysis of the quantitative PCR results was 
performed using the ViiA 7 software v1.2 (Applied Biosystems; Life Technologies).
Microarray
Accession code GSE71637. All the microarray data analysis was done using R and several 
packages available from CRAN53 and Bioconductor54. The raw data (CEL files) were 
normalized and summarized with the Robust MultiArray Average method implemented in 
the ‘oligo’ package55. Variations in gene expression levels were determined using ‘limma’ 
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package56 and only genes with fold-change higher than 2 were considered for downstream 
analysis.
Statistical analysis
The statistical significance of differences between populations was assessed with the 
Student’s t-test; P values of less than 0.05 were considered significant. Animal sample size 
was chosen to ensure significance of t-test. No animals were excluded. No randomization or 
blinding was performed. Data met normal distribution with similar variance between groups.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgements
We thank K. Serre, J. Martins, N. Schmolka, A. Amorim, V. Z. Luís and M. M. Mota (all iMM Lisboa); and B. 
Garcillán, D. de Juan, M. Mazariegos, M. Sanz-Rodríguez and S. Diaz-Castroverde (U. Complutense) for help and 
advice; A. Hayday (King’s College London) for insightful discussions; and the staff of our animal and flow 
cytometry facilities for technical assistance. This work was funded by the European Research Council (StG_260352 
and CoG_646701) to B.S.-S.; MINECO (SAF2011-24235 and BES-2012-055054), CAM (S2010/ 
BMD-2316/2326) and Lair (2012/0070) to J.R.R.; and FIS PI11/02198 and MINECO SAF2014-54708-R to E.F.-
M.
References
1. Wang T, et al. IFN-gamma-producing gamma delta T cells help control murine West Nile virus 
infection. J Immunol. 2003; 171:2524–2531. [PubMed: 12928402] 
2. Gao Y, et al. Gamma delta T cells provide an early source of interferon gamma in tumor immunity. J 
Exp Med. 2003; 198:433–442. [PubMed: 12900519] 
3. Jagannathan P, et al. Loss and dysfunction of Vdelta2(+) gammadelta T cells are associated with 
clinical tolerance to malaria. Sci Transl Med. 2014; 6:251ra117.
4. Cho JS, et al. IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection 
in mice. J Clin Invest. 2010; 120:1762–1773. [PubMed: 20364087] 
5. Sheridan BS, et al. gammadelta T cells exhibit multifunctional and protective memory in intestinal 
tissues. Immunity. 2013; 39:184–195. [PubMed: 23890071] 
6. Cai Y, et al. Pivotal role of dermal IL-17-producing gammadelta T cells in skin inflammation. 
Immunity. 2011; 35:596–610. [PubMed: 21982596] 
7. Pantelyushin S, et al. Rorgammat+ innate lymphocytes and gammadelta T cells initiate psoriasiform 
plaque formation in mice. J Clin Invest. 2012; 122:2252–2256. [PubMed: 22546855] 
8. Cai Y, et al. Differential developmental requirement and peripheral regulation for dermal Vgamma4 
and Vgamma6T17 cells in health and inflammation. Nat Commun. 2014; 5:3986. [PubMed: 
24909159] 
9. Park SG, et al. T regulatory cells maintain intestinal homeostasis by suppressing gammadelta T 
cells. Immunity. 2010; 33:791–803. [PubMed: 21074460] 
10. Romani L, et al. Defective tryptophan catabolism underlies inflammation in mouse chronic 
granulomatous disease. Nature. 2008; 451:211–215. [PubMed: 18185592] 
11. Shichita T, et al. Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the 
delayed phase of ischemic brain injury. Nat Med. 2009; 15:946–950. [PubMed: 19648929] 
12. Jensen KD, et al. Thymic selection determines gammadelta T cell effector fate: antigen-naive cells 
make interleukin-17 and antigen-experienced cells make interferon gamma. Immunity. 2008; 
29:90–100. [PubMed: 18585064] 
Muñoz-Ruiz et al. Page 10
Nat Immunol. Author manuscript; available in PMC 2016 December 01.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
13. Sutton CE, et al. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, 
amplifying Th17 responses and autoimmunity. Immunity. 2009; 31:331–341. [PubMed: 19682929] 
14. Petermann F, et al. gammadelta T cells enhance autoimmunity by restraining regulatory T cell 
responses via an interleukin-23-dependent mechanism. Immunity. 2010; 33:351–363. [PubMed: 
20832339] 
15. Prinz I, Silva-Santos B, Pennington DJ. Functional development of gammadelta T cells. Eur J 
Immunol. 2013; 43:1988–1994. [PubMed: 23928962] 
16. Ribot JC, et al. CD27 is a thymic determinant of the balance between interferon-gamma- and 
interleukin 17-producing gammadelta T cell subsets. Nat Immunol. 2009; 10:427–436. [PubMed: 
19270712] 
17. Haas JD, et al. CCR6 and NK1.1 distinguish between IL-17A and IFN--gamma-producing 
gammadelta effector T cells. Eur J Immunol. 2009; 39:3488–3497. [PubMed: 19830744] 
18. Rei M, et al. Murine CD27(-) Vgamma6(+) gammadelta T cells producing IL-17A promote 
ovarian cancer growth via mobilization of protumor small peritoneal macrophages. Proc Natl Acad 
Sci U S A. 2014; 111:E3562–3570. [PubMed: 25114209] 
19. Wu P, et al. gammadeltaT17 cells promote the accumulation and expansion of myeloid-derived 
suppressor cells in human colorectal cancer. Immunity. 2014; 40:785–800. [PubMed: 24816404] 
20. Silva-Santos B, Serre K, Norell H. Gamma-delta T cells in cancer. Nat Rev Immunol. 2015; 
15:683–691. [PubMed: 26449179] 
21. Turchinovich G, Hayday AC. Skint-1 identifies a common molecular mechanism for the 
development of interferon-gamma-secreting versus interleukin-17-secreting gammadelta T cells. 
Immunity. 2011; 35:59–68. [PubMed: 21737317] 
22. Wencker M, et al. Innate-like T cells straddle innate and adaptive immunity by altering antigen-
receptor responsiveness. Nat Immunol. 2014; 15:80–87. [PubMed: 24241693] 
23. Ciofani M, Zuniga-Pflucker JC. Determining gammadelta versus alphass T cell development. Nat 
Rev Immunol. 2010; 10:657–663. [PubMed: 20725107] 
24. Haks MC, et al. Attenuation of gammadeltaTCR signaling efficiently diverts thymocytes to the 
alphabeta lineage. Immunity. 2005; 22:595–606. [PubMed: 15894277] 
25. Hayes SM, Li L, Love PE. TCR signal strength influences alphabeta/gammadelta lineage fate. 
Immunity. 2005; 22:583–593. [PubMed: 15894276] 
26. O'Brien RL, Born WK. gammadelta T cell subsets: a link between TCR and function? Semin 
Immunol. 2010; 22:193–198. [PubMed: 20451408] 
27. Narayan K, et al. Intrathymic programming of effector fates in three molecularly distinct 
gammadelta T cell subtypes. Nat Immunol. 2012; 13:511–518. [PubMed: 22473038] 
28. Malhotra N, et al. A network of high-mobility group box transcription factors programs innate 
interleukin-17 production. Immunity. 2013; 38:681–693. [PubMed: 23562159] 
29. Dave VP, et al. CD3 delta deficiency arrests development of the alpha beta but not the gamma delta 
T cell lineage. EMBO J. 1997; 16:1360–1370. [PubMed: 9135151] 
30. Coffey F, et al. The TCR ligand-inducible expression of CD73 marks gammadelta lineage 
commitment and a metastable intermediate in effector specification. J Exp Med. 2014; 211:329–
343. [PubMed: 24493796] 
31. Azzam HS, et al. CD5 expression is developmentally regulated by T cell receptor (TCR) signals 
and TCR avidity. J Exp Med. 1998; 188:2301–2311. [PubMed: 9858516] 
32. Haas JD, et al. Development of interleukin-17-producing gammadelta T cells is restricted to a 
functional embryonic wave. Immunity. 2012; 37:48–59. [PubMed: 22770884] 
33. Schmolka N, et al. Epigenetic and transcriptional signatures of stable versus plastic differentiation 
of proinflammatory gammadelta T cell subsets. Nat Immunol. 2013; 14:1093–1100. [PubMed: 
23995235] 
34. Schmolka N, Wencker M, Hayday AC, Silva-Santos B. Epigenetic and transcriptional regulation of 
gammadelta T cell differentiation: Programming cells for responses in time and space. Semin 
Immunol. 2015; 27:19–25. [PubMed: 25726512] 
35. Silva-Santos B, Pennington DJ, Hayday AC. Lymphotoxin-mediated regulation of gammadelta cell 
differentiation by alphabeta T cell progenitors. Science. 2005; 307:925–928. [PubMed: 15591166] 
Muñoz-Ruiz et al. Page 11
Nat Immunol. Author manuscript; available in PMC 2016 December 01.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
36. Kannan Y, et al. IkappaBzeta augments IL-12- and IL-18-mediated IFN--gamma production in 
human NK cells. Blood. 2011; 117:2855–2863. [PubMed: 21224476] 
37. Gu X, et al. The gp49B1 inhibitory receptor regulates the IFN--gamma responses of T cells and 
NK cells. J Immunol. 2003; 170:4095–4101. [PubMed: 12682239] 
38. Ribot JC, et al. Cutting edge: adaptive versus innate receptor signals selectively control the pool 
sizes of murine IFN--gamma- or IL-17-producing gammadelta T cells upon infection. J Immunol. 
2010; 185:6421–6425. [PubMed: 21037088] 
39. Rudin W, Favre N, Bordmann G, Ryffel B. Interferon-gamma is essential for the development of 
cerebral malaria. Eur J Immunol. 1997; 27:810–815. [PubMed: 9130629] 
40. Chien YH, Meyer C, Bonneville M. gammadelta T cells: first line of defense and beyond. Annu 
Rev Immunol. 2014; 32:121–155. [PubMed: 24387714] 
41. Hayes SM, Love PE. Distinct structure and signaling potential of the gamma delta TCR complex. 
Immunity. 2002; 16:827–838. [PubMed: 12121664] 
42. Hayes SM, Love PE. Stoichiometry of the murine gammadelta T cell receptor. J Exp Med. 2006; 
203:47–52. [PubMed: 16418397] 
43. Siegers GM, et al. Different composition of the human and the mouse gammadelta T cell receptor 
explains different phenotypes of CD3gamma and CD3delta immunodeficiencies. J Exp Med. 
2007; 204:2537–2544. [PubMed: 17923503] 
44. Zapata DA, et al. Conformational and biochemical differences in the TCR.CD3 complex of 
CD8(+) versus CD4(+) mature lymphocytes revealed in the absence of CD3gamma. J Biol Chem. 
1999; 274:35119–35128. [PubMed: 10574994] 
45. Fernandez-Malave E, et al. Overlapping functions of human CD3delta and mouse CD3gamma in 
alphabeta T-cell development revealed in a humanized CD3gamma-mouse. Blood. 2006; 
108:3420–3427. [PubMed: 16888097] 
46. Hayes SM, et al. Activation-induced modification in the CD3 complex of the gammadelta T cell 
receptor. J Exp Med. 2002; 196:1355–1361. [PubMed: 12438426] 
47. Jin Y, et al. Cutting edge: Intrinsic programming of thymic gammadeltaT cells for specific 
peripheral tissue localization. J Immunol. 2010; 185:7156–7160. [PubMed: 21068400] 
48. Roark CL, et al. Exacerbation of collagen-induced arthritis by oligoclonal, IL-17-producing 
gamma delta T cells. J Immunol. 2007; 179:5576–5583. [PubMed: 17911645] 
49. Mahtani-Patching J, et al. PreTCR and TCRgammadelta signal initiation in thymocyte progenitors 
does not require domains implicated in receptor oligomerization. Sci Signal. 2011; 4:ra47. 
[PubMed: 21775286] 
50. Seiler MP, et al. Elevated and sustained expression of the transcription factors Egr1 and Egr2 
controls NKT lineage differentiation in response to TCR signaling. Nat Immunol. 2012; 13:264–
271. [PubMed: 22306690] 
51. Haks MC, Krimpenfort P, Borst J, Kruisbeek AM. The CD3gamma chain is essential for 
development of both the TCRalphabeta and TCRgammadelta lineages. EMBO J. 1998; 17:1871–
1882. [PubMed: 9524111] 
52. Liehl P, et al. Host-cell sensors for Plasmodium activate innate immunity against liver-stage 
infection. Nat Med. 2014; 20:47–53. [PubMed: 24362933] 
53. Team RA. A language and environment for statistical computing. Vienna, Austria. 2011
54. Huber W, et al. Orchestrating high-throughput genomic analysis with Bioconductor. Nat Methods. 
2015; 12:115–121. [PubMed: 25633503] 
55. Carvalho BS, Irizarry RA. A framework for oligonucleotide microarray preprocessing. 
Bioinformatics. 2010; 26:2363–2367. [PubMed: 20688976] 
56. Ritchie ME, et al. limma powers differential expression analyses for RNA-sequencing and 
microarray studies. Nucleic Acids Res. 2015; 43:e47. [PubMed: 25605792] 
Muñoz-Ruiz et al. Page 12
Nat Immunol. Author manuscript; available in PMC 2016 December 01.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Figure 1. γδ T cells from CD3DH mice show reduced TCRγδ expression and signaling
(a) Flow cytometry showing the CD3ε vs TCRδ phenotype of thymocytes from one-week 
old wildt-ype (WT) or Cd3g+/− Cd3d+/− (CD3DH) mice (n = 10 per group). Numbers within 
outlined areas or quadrants indicate % cells in each throughout. (b-f) TCRγδ MFI (b) and γδ 
thymocyte numbers (c) gated as in (a), CD8 vs CD4 phenotype of thymocytes (n = 3 per 
group of adult mice) (d), TCRαβ MFI (e) and absolute numbers of TCRβ+CD3+ thymocytes 
(f). (g-i) Flow cytometry showing expression of the indicated agonist selection and 
maturation markers in gated TCRδ+CD3+CD27+ thymocytes (g), of CD69 and CD25 in 
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sorted TCRδ+CD3+CD27+ spleen cells stimulated with plate-coated α-CD3ε mAb for 24h 
(h), of phosphorylated Erk1/Erk2 (empty histograms) vs isotype-matched background 
staining (filled histograms) in sorted TCRδ+CD3+CD27+ lymph node cells stimulated for 5 
min with soluble α-CD3ε mAb (i). Data are representative of 3 independent experiments. (j, 
k) Flow cytometry showing comparative TCRγδ MFI (j) and Thy-1.1( WT-derived) vs 
Thy-1.2 (CD3DH-derived) fractions among gated TCRδ+CD3+ and CD4+CD3+ thymocytes 
(k) from 1:1 mixed WT:CD3DH bone marrow chimeras. Each symbol indicates one host, 
either RAG2−/− (squares) or TCRδ−/− (triangles). In (b,c) and (e,f), dots represent individuals 
and horizontal lines mean ± s.d. NS, not significant; *P < 0.01 (Student’s t-test).
Muñoz-Ruiz et al. Page 14
Nat Immunol. Author manuscript; available in PMC 2016 December 01.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Figure 2. CD3DH mice show impaired differentiation of IL-17+ and IFN-γ+ γδ T cells within 
selective windows of TCR Vγ usage
(a-c) Flow cytometry at various developmental stages showing representative surface CD27 
expression in gated CD3+TCRδ+ thymocytes (n = 10 per mice group) (a), intracellular IL-17 
in CD3+TCRδ+CD27− thymocytes ( b ) and IFN-γ expression in CD3+TCRδ+ CD27+ 
thymocytes (c) from WT or CD3DH mice following stimulation with PMA and ionomycin. 
Data are representative of two to four experiments per developmental stage. Numbers 
indicate the % cells in the marked region. (d) Percent CD27−IL-17+ (top) and CD27+IFN-γ+ 
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(bottom) γδ T cells in WT and CD3DH mice (n = 5 per group) as determined in (b) and (c), 
respectively. Data shown are the mean +/− s.d. *P < 0.05; **P < 0.01 (Student’s t-test). (e) 
Vγ usage by CD27−IL-17+ or CD27+IFN-γ+ γδ T cells at various developmental stages (n = 
7 per group), as determined by flow cytometry. (f) Flow cytometry showing intracellular 
IL-17 expression in CD3+TCRδ+CD27− thymocytes from E18 WT or CD3DH mice 
following stimulation with PMA and ionomycin. Numbers indicate % cells in the marked 
region.
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Figure 3. Transcriptional signatures of TCR signal strength in γδ thymocytes
(a) Microarray heatmap of differentially expressed genes during ontogeny in sorted 
CD3+TCRδ+ γδ thymocytes of WT or CD3DH mice (>2-fold adult/fetal between week 5-7 
and E18). (b) Fold expression by real-time RT-PCR (in arbitrary units normalized to the 
housekeeping gene Hprt) of Egr2, Egr3, Nt5e (encoding CD73), Sox4, Il23r and Ilr1 genes 
by sorted CD3+TCRδ+γδ thymocytes from WT or CD3DH mice before and after 16h 
stimulation with α-CD3ε mAb (10 μg/ml). Data shown are the mean +/− s.d. *P < 0.05; **P 
< 0.01 (Student’s t-test).
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Figure 4. CD3DH mice lack IFN-γ hi CD122+ NK1.1+ thymocytes that are rescued by CD3 
crosslinking in vivo
(a) Flow cytometry showing representative NK1.1 vs CD122 expression in 
TCRδ+CD3+CD27+ thymocytes isolated from adult WT or CD3DH mice (n = 10 per group). 
Numbers indicate % cells in each quadrant. (b) Frequencies (left) and total numbers (right) 
of TCRδ+CD3+CD27+CD122+NK1.1+ thymocytes. Each dot represents an individual 
mouse; bars indicate the mean +/− s.d. *P < 0.01 (Student’s t-test) throughout. (c, d) Flow 
cytometry showing representative Vγ1 vs Vγ4 chain usage (c) and surface CD44, CD73, 
CD45RB or intracellular IFN-γ production (d) by the indicated gated TCRδ+CD3+CD27+ 
thymocyte subsets from adult WT mice (n = 5 per group). Data are representative of at least 
three independent experiments. (e) Flow cytometry showing representative NK1.1 vs CD122 
expression (top) within Thy-1.1+ ( WT-derived) or Thy-1.2+ (CD3DH-derived) fractions 
(bottom) of TCRδ+CD3+CD27+CD122+NK1.1+ thymocytes from 1:1 or 1:9 mixed bone 
marrow chimeras. Each symbol indicates one host, either RAG2−/− (squares) or TCRδ−/− 
(triangles). (f, g) Flow cytometry showing representative NK1.1 vs CD122 expression (f) 
and % (left) and numbers (right) of TCRγδ+CD3+CD27+ CD122+NK1.1+ thymocytes (g) in 
WT or CD3DH mice, 5 days after i.p. injection of α-CD3 mAb 17A2 ( n = 3 per group). 
Each dot represents an individual mouse; bars indicate the mean +/− s.d.
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Figure 5. CD3DH mice show reduced peripheral IFN-γ+ γδ T cells and are resistant to cerebral 
malaria
(a,b) Intracellular IFN-γ (top) or IL-17 (bottom) expression in CD27+ or CD27− 
TCRδ+CD3+ adult mice splenocytes, respectively, stimulated with PMA and ionomycin (a). 
Numbers indicate % of cells in the marked region, which are shown for n = 5 per group in 
(b). (c, d) NK1.1 vs CD122 expression in TCRδ+CD3+CD27+ adult mice splenocytes (c). 
Numbers indicate % of cells in each quadrant, which are shown in (d) for n = 20 per group 
as % (left) or total numbers (right). (e) Thy-1.1 (WT-derived) vs Thy-1.2 ( CD3DH-derived) 
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fractions among TCRδ+CD3+CD27+CD122+NK1.1+ splenocytes from 1:1 or 1:9 mixed 
WT:CD3DH BM chimeras. Each symbol indicates one host, either RAG2−/− (squares) or 
TCRδ−/− (triangles). (f) Comparative surface expression of the indicated markers in 
CD122−NK1.1− vs CD122+NK1.1+ cells gated on WT TCRγδ+CD3+ CD27+ splenocytes. 
(g, h) Intracellular IFN-γ expression (after PMA and ionomycin stimulation) in 
TCRγδ+CD3+CD27+ splenocytes sorted 5 days after infection with Plasmodium berghei 
ANKA sporozoites. Numbers above plots indicate mean +/− s.d. absolute counts of IFN-γ+ 
γδ cells (g). Parasitemia as % blood GFP+ cells 5 days after infection (h). (i) Survival curves 
of n = 10 mice infected as in (g) in two independent experiments. Data in (a) and (e) are 
representative of n = 3 independent experiments. Error bars indicate s.d. of the mean and 
dots represent individual mice throughout. *P < 0.05, **P < 0.01 (Student’s t-test).
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